Insilico Medicine’s $80 Million Agreement with Exelixis

Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the transaction.Exelixis, Inc. and Insilico Medicine announced that they have entered into an exclusive license agreement granting Exelixis global…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here